If the patient has no renal failure, why is her potassium so high?: Candesartan, spironolactone

Jennifer A. Rabbitts; Wayne T. Nicholson; Juraj Sprung

doi:10.1007/978-1-4614-7495-1_123

If the patient has no renal failure, why is her potassium so high? Candesartan, spironolactone

Jennifer A. Rabbitts, Wayne T. Nicholson, Juraj Sprung

Anesthesiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This case discusses the pharmacodynamic interaction between candesartan and spironolactone, resulting in hyperkalemia. Candesartan is angiotensin II receptor blocker and spironolactone is a potassium-sparing diuretic.

Original language	English (US)
Title of host publication	A Case Approach to Perioperative Drug-Drug Interactions
Publisher	Springer New York
Pages	555-561
Number of pages	7
ISBN (Electronic)	9781461474951
ISBN (Print)	9781461474944
DOIs	https://doi.org/10.1007/978-1-4614-7495-1_123
State	Published - Sep 15 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4614-7495-1_123

Cite this

@inbook{e941594734514cf2a4e7e6345d7114e5,

title = "If the patient has no renal failure, why is her potassium so high?: Candesartan, spironolactone",

abstract = "This case discusses the pharmacodynamic interaction between candesartan and spironolactone, resulting in hyperkalemia. Candesartan is angiotensin II receptor blocker and spironolactone is a potassium-sparing diuretic.",

author = "Rabbitts, {Jennifer A.} and Nicholson, {Wayne T.} and Juraj Sprung",

year = "2015",

month = sep,

day = "15",

doi = "10.1007/978-1-4614-7495-1_123",

language = "English (US)",

isbn = "9781461474944",

pages = "555--561",

booktitle = "A Case Approach to Perioperative Drug-Drug Interactions",

publisher = "Springer New York",

}

TY - CHAP

T1 - If the patient has no renal failure, why is her potassium so high?

T2 - Candesartan, spironolactone

AU - Rabbitts, Jennifer A.

AU - Nicholson, Wayne T.

AU - Sprung, Juraj

PY - 2015/9/15

Y1 - 2015/9/15

N2 - This case discusses the pharmacodynamic interaction between candesartan and spironolactone, resulting in hyperkalemia. Candesartan is angiotensin II receptor blocker and spironolactone is a potassium-sparing diuretic.

AB - This case discusses the pharmacodynamic interaction between candesartan and spironolactone, resulting in hyperkalemia. Candesartan is angiotensin II receptor blocker and spironolactone is a potassium-sparing diuretic.

UR - http://www.scopus.com/inward/record.url?scp=84955356099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955356099&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7495-1_123

DO - 10.1007/978-1-4614-7495-1_123

M3 - Chapter

AN - SCOPUS:84955356099

SN - 9781461474944

SP - 555

EP - 561

BT - A Case Approach to Perioperative Drug-Drug Interactions

PB - Springer New York

ER -

If the patient has no renal failure, why is her potassium so high? Candesartan, spironolactone

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this